The Role of Natural Products in Combating Antimicrobial Resistance

Cabello Asako^*
*Correspondence: Cabello Asako, Department of Biological Sciences, University of Omaha, Omaha, USA, Email:

Introduction

The global rise of antimicrobial resistance (AMR) has emerged as one of the most pressing health challenges of our time. The increasing prevalence of resistant pathogens is outpacing the development of new antibiotics, leading to a potential crisis where common infections may once again become untreatable. Amid this growing concern, natural products have gained attention as a promising solution to combat AMR, offering novel mechanisms of action, diverse chemical structures, and reduced resistance development compared to traditional synthetic drugs.

Natural products, derived from plants, microorganisms, marine organisms, and other natural sources, have a long history in medicine [1]. Many of the antibiotics in use today, including penicillin, tetracyclines, and aminoglycosides, were originally derived from natural sources. These substances often possess complex structures that are difficult to replicate synthetically, contributing to their unique bioactivity. In the face of AMR, the exploration of natural products has become increasingly important, as they offer a vast and largely untapped reservoir of chemical diversity that could yield new antimicrobial agents.

One of the significant advantages of natural products in combating AMR is their potential to act on multiple targets within microbial cells. Unlike many synthetic antibiotics, which often target a single bacterial process, natural compounds frequently exhibit multifaceted modes of action. This multifactorial approach can reduce the likelihood of resistance development, as pathogens would need to simultaneously mutate several targets to evade the drug's effects. For instance, certain plant-derived compounds, such as alkaloids, terpenoids, and flavonoids, have demonstrated the ability to disrupt bacterial cell walls, interfere with nucleic acid synthesis, and inhibit protein production, thereby exerting broad-spectrum antimicrobial activity [2].

Description

The resurgence of interest in natural products is also driven by the discovery of novel sources and improved methods of extraction and identification. Advances in technology, such as high-throughput screening, genomics, and metabolomics, have significantly enhanced the ability to identify bioactive compounds from natural sources. Marine environments, in particular, have emerged as a rich and relatively unexplored source of new antimicrobial agents. Marine organisms, including sponges, algae, and marine bacteria, produce a wide array of secondary metabolites with potent antimicrobial properties. For example, compounds like bryostatin from marine bryozoans and plakortin from marine sponges have shown promise in combating resistant bacterial strains, underscoring the potential of marine biodiversity in addressing AMR.

Another promising avenue in the fight against AMR is the use of natural products in combination with existing antibiotics. The synergistic effects of combining natural compounds with conventional antibiotics can enhance the efficacy of treatment and potentially reverse resistance. This approach, known as antibiotic potentiation, has shown success in several studies. For instance, the combination of the flavonoid baicalein with traditional antibiotics such as tetracycline or ciprofloxacin has been shown to restore the effectiveness of these drugs against resistant strains of Staphylococcus aureus. By weakening the bacterial defense mechanisms, natural products can sensitize pathogens to antibiotics, reducing the required dose and minimizing side effects.

The exploration of natural products also extends to their potential role in modulating the host immune response to infections. Some natural compounds possess immunomodulatory properties that can enhance the body's ability to fight off infections. For example, certain polysaccharides from medicinal mushrooms, such as beta-glucans, have been found to stimulate immune cells and improve the body's resistance to bacterial infections [3]. By boosting the host's innate immunity, these natural products may provide an adjunctive strategy to combat AMR, reducing the reliance on antibiotics and lowering the risk of resistance development.

Despite the promising potential of natural products, several challenges remain in their development as antimicrobial agents. One significant hurdle is the complexity of isolating and characterizing active compounds from natural sources. The chemical diversity of natural products, while advantageous for bioactivity, also presents challenges in standardization, reproducibility, and large-scale production. Additionally, the development pipeline for natural product-derived drugs can be lengthy and costly, requiring extensive research, clinical trials, and regulatory approval. Nevertheless, ongoing efforts in drug discovery, coupled with advancements in biotechnology and synthetic biology, are gradually overcoming these obstacles, paving the way for the successful translation of natural products into clinically useful antimicrobials [4].

Moreover, the integration of traditional knowledge with modern scientific approaches has the potential to accelerate the discovery of new antimicrobial agents from natural products. Indigenous and traditional medicine systems have long utilized natural substances for their therapeutic properties, and these practices provide valuable insights into potential sources of new antibiotics [5]. By combining ethnopharmacology with cutting-edge research tools, scientists can identify and validate the antimicrobial properties of traditional remedies, leading to the discovery of novel compounds that may otherwise remain hidden.

Conclusion

In conclusion, the role of natural products in combating antimicrobial resistance is both significant and multifaceted. As the threat of AMR continues to escalate, the exploration of natural sources for new antimicrobial agents offers a promising avenue for addressing this global health crisis. Natural products, with their diverse chemical structures, multifaceted mechanisms of action, and potential for combination therapies, represent a valuable resource in the search for new solutions to AMR. While challenges remain in their development and commercialization, the ongoing efforts in research and drug discovery hold the potential to unlock the vast therapeutic potential of nature, providing new hope in the fight against resistant infections. As we look to the future, the integration of natural products into the arsenal against AMR will be crucial in safeguarding public health and ensuring the continued effectiveness of antibiotics for generations to come.

Acknowledgement

None.

Conflict of Interest

None.

References

1. Pal, Chandan, Johan Bengtsson-Palme, Erik Kristiansson and DG Joakim Larsson. "The structure and diversity of human, animal and environmental resistomes." Microbiome 4 (2016): 1-15.

Google Scholar, Crossref, Indexed at

2. Manaia, Célia M. "Assessing the risk of antibiotic resistance transmission from the environment to humans: Non-direct proportionality between abundance and risk." Trends Microbiol 25 (2017): 173-181.

Google Scholar, Crossref, Indexed at

3. Forsberg, Kevin J., Alejandro Reyes, Bin Wang and Elizabeth M. Selleck, et al. "The shared antibiotic resistome of soil bacteria and human pathogens." Sci 337 (2012): 1107-1111.

Google Scholar, Crossref, Indexed at

4. Shiu, Winnie KP, John P. Malkinson, M. Mukhlesur Rahman and Jonathan Curry, et al. "A new plant-derived antibacterial is an inhibitor of efflux pumps in staphylococcus aureus." Int J Antimicrob Agents 42 (2013): 513-518.

Google Scholar, Crossref, Indexed at

5. Espinoza, Javier, Alejandro Urzúa, Loreto Sanhueza and Mariana Walter, et al. "Essential oil, extracts, and sesquiterpenes obtained from the heartwood of pilgerodendron uviferum act as potential inhibitors of the Staphylococcus aureus NorA multidrug efflux pump." Front Microbiol 10 (2019): 337.

Google Scholar, Crossref, Indexed at